000 | 01546 a2200457 4500 | ||
---|---|---|---|
005 | 20250514030017.0 | ||
264 | 0 | _c20020920 | |
008 | 200209s 0 0 eng d | ||
022 | _a0920-3206 | ||
024 | 7 |
_a10.1023/a:1013707503018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aParsons, R W | |
245 | 0 | 0 |
_aPrior calcium channel blockade and short-term survival following acute myocardial infarction. _h[electronic resource] |
260 |
_bCardiovascular drugs and therapy _cNov 2001 |
||
300 |
_a487-92 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aAustralia _xepidemiology |
650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
650 | 0 | 4 |
_aDiltiazem _xtherapeutic use |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
650 | 0 | 4 |
_aNifedipine _xtherapeutic use |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVerapamil _xtherapeutic use |
700 | 1 | _aHung, J | |
700 | 1 | _aHanemaaijer, I | |
700 | 1 | _aJbroadhurst, R | |
700 | 1 | _aJamrozik, K | |
700 | 1 | _aHobbs, M S | |
773 | 0 |
_tCardiovascular drugs and therapy _gvol. 15 _gno. 6 _gp. 487-92 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1013707503018 _zAvailable from publisher's website |
999 |
_c11821609 _d11821609 |